(781) 776-1944 Request a Consultation
Spravato treatment at Emerge Therapy
SPRAVATO® TREATMENT · WOBURN & DANVERS, MA

When antidepressants haven't worked, there's still a path forward.

Spravato is an FDA-approved nasal spray for treatment-resistant depression — physician-overseen, most insurance accepted, and available at our Woburn and Danvers locations. Start with a free telehealth consultation, no pressure or obligation.

Request a Consultation See If It's Right For Me
Medicaid Accepted Most Insurance Accepted
IS THIS YOU?

Reasons people try Spravato.

Spravato was built for people who've already put in the work — therapy, medication, time — and still haven't found relief. Tap any of these to learn more.

I've tried 2+ antidepressants with little relief
This is the clinical definition of treatment-resistant depression, and it's exactly who Spravato was developed for.
I still feel persistently low or hopeless
Ongoing low mood despite treatment is one of the most common reasons patients look into Spravato.
I've lost interest in things I used to enjoy
Loss of interest or pleasure is a core depressive symptom Spravato is studied to help improve.
I have thoughts that life isn't worth living
Spravato is also FDA-approved specifically for MDD with suicidal ideation, under close clinical supervision.
I'm exhausted by trial-and-error medication
Spravato works differently than oral antidepressants, targeting NMDA receptors rather than monoamine levels.
I need to feel better sooner, not months from now
Unlike most oral antidepressants, clinical studies observed a difference as early as 24 hours after the first dose.
A QUICK SELF-CHECK

Could Spravato be worth exploring?

This isn't a diagnosis — just three questions to help you think it through before your consultation.

1. Have you tried two or more antidepressants without lasting relief?
2. Are you still experiencing persistent low mood or hopelessness?
3. Would you be open to starting with a telehealth evaluation from home?

That's worth a conversation.

Based on what you shared, it may be worth talking through your options with our clinical team. A free consultation is a no-pressure way to find out if Spravato — or something else — is the right next step.

Request a Consultation
HOW SPRAVATO HELPS

Relief that works differently.

Rapid relief for patients who haven't responded to traditional antidepressants, often within hours to weeks rather than months.

FDA-approved for treatment-resistant depression and MDD with suicidal ideation — reviewed and confirmed safe and effective for its intended use.

Mostly covered by insurance — we're in-network with several leading providers to help keep costs manageable.

Request a Consultation
How Spravato helps patients at Emerge Therapy
THE RESEARCH

What clinical studies found.

Spravato has been studied extensively since its FDA approval. Here's some of what the research shows.

53%

greater reduction in depression symptoms with Spravato + an oral antidepressant vs. placebo + an oral antidepressant, in a pivotal 4-week trial.1

24 hrs

Improvement was observed as early as 24 hours after the first treatment in clinical studies, with continued improvement through Day 28.1

51%

lower risk of relapse for patients in stable remission who continued Spravato, compared to those who switched to placebo.2

26.7%

of patients who continued Spravato relapsed, compared to 45.3% of those who discontinued it for placebo.2

1. SPRAVATO® Prescribing Information. janssenlabels.com
2. Daly EJ, et al. Efficacy of Esketamine Nasal Spray Plus Oral Antidepressant for Relapse Prevention in Treatment-Resistant Depression. pmc.ncbi.nlm.nih.gov
Individual results vary. These figures reflect clinical trial populations and may not predict individual outcomes.
WHY EMERGE

Physician-led. Judgment-free.

Emerge was founded by board-certified Emergency Physicians who bring medical rigor and genuine compassion to every consultation. We won't tell you what treatment you need — we'll help you figure out what might actually be right for you, and stay with you through the whole process, not just the prescription.

Learn More
Dr. Liam Mahoney

Dr. Liam Mahoney

Co-Founder, Board-Certified Emergency Physician

Boston-based physician with extensive clinical experience in Emergency Medicine across Eastern Massachusetts.

Dr. Joseph Benedict

Dr. Joseph Benedict

Co-Founder, Board-Certified Emergency Physician

MPH and MD from the University of Washington, now practicing Emergency Medicine throughout New England.

FROM OUR PATIENTS

Trusted by people who've been where you are.

"

Since my initial intake with Beth, I have nothing but praise for the staff. The level of professionalism and attentiveness has been such a delight. Melissa, Paula and Luke have been amazing throughout the whole process. The treatment has helped me so much in relation to my depression and anxiety. Still have some off days which are a lot more controllable. Keep up the good work and positive vibes.

SCOTTIE
"

The best place and treatment I have ever tried. I have tried every antidepressant out there and nothing has made a difference. My girlfriend and family have noticed a huge change in me. The staff at Emerge are so friendly and nice I can't recommend this place enough. Paula is the best! She is so caring and friendly.

ROB
"

I'm truly excited about the beautiful new office and the incredible team that works there. Every person I've encountered has been kind, compassionate, and full of grace—beautiful spirits genuinely dedicated to supporting you on your journey toward peace, healing, and mental wellness. I wholeheartedly recommend them to anyone seeking care and support.

ARYANNA
COVERAGE

Spravato is covered by the following insurance providers.

Aetna Cigna BCBS of Mass Humana MassHealth
GET STARTED

Three simple steps.

01

Request a Consultation

Fill out the form below — no cost, no obligation.

02

Telehealth Evaluation

Talk through your history with our clinical team from home.

03

Begin Treatment

Start Spravato at our Woburn or Danvers location.

Request Your Consultation

Fill out the form below and a member of our team will follow up to help you get started.

FREQUENTLY ASKED QUESTIONS

Your Spravato questions, answered.

Yes. Spravato was FDA approved for treatment-resistant depression in 2019, and for Major Depressive Disorder with acute suicidal ideation in 2020.
Most insurance plans do cover Spravato. We're in-network with several leading providers, including Aetna, Cigna, BCBS of Mass, Humana, and MassHealth. We'll verify your benefits before starting treatment.
Spravato is a self-administered nasal spray, given in-office under observation by our clinical team, typically 1–2 times per week.
In clinical studies, improvement was observed as early as 24 hours after the first treatment, with continued improvement through the first month.
Adults with a formal diagnosis of treatment-resistant depression, or Major Depressive Disorder with suicidal ideation. If you don't meet either, our IV ketamine services may be a better fit.
Emerge Therapy patient feeling supported

Let's figure out what might actually help.

Request a free consultation — no pressure, no obligation. Just a conversation about where you are and what's possible.

Request a Consultation